Latest news
Definium Therapeutics (DFTX) Reports Strong Phase III Data, Is It Still Below Fair Value? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 21:28:36 GMTFlood Re reports strong financial performance as it enters next phase focused on resilience and targeted support - Claims MediaClaims Media · Wed, 05 Aug 2026 09:03:51 GMTIMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer - GlobeNewswireGlobeNewswire · Thu, 30 Jul 2026 13:00:00 GMTPurepoint Uranium reports strong radioactive intercept at Nova discovery - Proactive financial newsProactive financial news · Thu, 30 Jul 2026 07:00:00 GMTPrescient Therapeutics Reports Strong Progress in PTX-100 Phase 2a Study and New CMO Appointment - KalkineKalkine · Mon, 27 Jul 2026 07:00:00 GMT